Serum levels of bone-origin alkaline phosphatase and of tartrateresistant acid phosphatase were measured in Caucasian women aged 41-69 years who had volunteered for bone densitometry. Bone alkaline phosphatase and tartrateresistant acid phosphatase were inversely correlated with vertebral bone density and with femoral neck bone density. Bone alkaline phosphatase and acid phosphatase were also significantly correlated, consistent with the concept of 'coupling' between osteoblast and osteoclast activity.
SUMMARY. Serum levels of bone-origin alkaline phosphatase and of tartrateresistant acid phosphatase were measured in Caucasian women aged 41-69 years who had volunteered for bone densitometry. Bone alkaline phosphatase and tartrateresistant acid phosphatase were inversely correlated with vertebral bone density and with femoral neck bone density. Bone alkaline phosphatase and acid phosphatase were also significantly correlated, consistent with the concept of 'coupling' between osteoblast and osteoclast activity.
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OsteoporosisI is the major bone disease of the Western world. 2 -4 The most frequent type is postmenopausal osteoporosis, which will affect most women by the end of their lives. The disorder arises from loss of bone matrix leading on to bone deformity and fractures especially of the vertebrae, radius and femoral neck. 2 -4 Bone matrix is synthesized by osteoblasts: these cells produce alkaline phosphatase.f-" Bone resorption is carried out by osteo clasts which are rich in tartrate-resistant acid phosphatase.V Osteoblasts and osteoclasts interact throughout life to carry out a sequence of resorption of bone followed by formation: this process has been called 'coupling'? and is regulated by both systemic and local factors.v" The underlying cellular defect in osteoporosis is believed to be an 'uncoupling' of bone formation and resorption leading to an increase in resorption relative to formation. 8 In order to identify osteoporosis and potential fracture risk, conventional radiography, photon absorptionimetry or quantitative computerized tomography may be used to estimate bone density. Of these, photon absorptionimetry combines sensitivity and economy, and is widely available. Using this technique, Christiansen's group? showed that a single measurement of Correspondence: Dr S B Rosalki. bone mineral content of the forearm combined with a biochemical assessment of bone loss could identify women at highest risk of subsequent bone loss. They included measurement of serum total alkaline phosphatase in their biochemical assessment but recognized that newer markers of bone formation might improve the value of their biochemical model. 9 Since quantitation of the bone isoenzyme of alkaline phosphatase can now be readily performed in the clinical laboratory;" we have studied this fraction of alkaline phosphatase. We measured the activities of bone-derived alkaline phosphatase and tartrateresistant acid phosphatase in sera as indices of osteoblast and osteoclast activity, respectively, and compared these results with bone density measurements of perimenopausal Caucasian women in order to ascertain if a relationship exists.
METHODS
We studied 60 healthy Caucasian women aged between 41 and 69 years who answered an advertisement in a local newspaper asking for volunteers. Details about the women including menopausal status were established by using a questionnaire, and the women were not taking any medication. Routine serum analyses of renal, liver and bone biochemistry were within reference ranges. Approval for the study was obtained from the hospital ethical committee.
We measured bone density with a NOVO BMC-LAB 22a dual photon densitometer (NOVO Diagnostic Systems, Denmark) using a 153gadolinium source with a resolution of 4 mm. The densitometer was calibrated daily using a one inch thick aluminium rod immersed in water. Densities of the L2-L4 region and the mid-section of the right femoral neck were calculated (coefficient of variation < 2070) and results expressed as grams of hydroxyapatite per square centimetre.
We measured total alkaline phosphatase (orthophosphoric monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1) activity in accordance with the International Federation of Clinical Chemistry (IFCC) recommendation, but at 37°C, using 4-nitrophenylphosphate as substrate and 2-amino-2-methyl-1-propanol as buffer.11 Alkaline phosphatase isoenzyrnes were separated using wheat-germ lectin affinity electrophoresis and the bone fraction was measured by densitometry. 10 The between-batch coefficient of variation (CV) for bone-derived alkaline phosphatase at an activity of 60 U/L was 5% and the within-batch CV was 3'2%.
Tartrate-resistant acid phosphatase activity (acid phosphatase: orthophosphoric monoester phosphohydrolase, acid optimum, EC 3.1.3.2) was measured at 37°C using 4-nitrophenylphosphate as substrate.P'P The between-batch and within-batch CVs for tartrate-resistant acid phosphatase were both < 6% at 14U/L. Reagents for alkaline phosphatase and acid phosphatase measurements were obtained from Boehringer Mannheim Ltd, Lewes, UK. Correlation analyses were carried out by least squares regression analysis. Bone density values were compared using a two-tailed t-test on unpaired data. years of the menopause) and women aged 60-69 years had bone densities of 0·75 (0'10) gHA/cm 2 (all were postmenopausal). Women aged 60-69 years had a statistically significant lower bone density than women aged 50-59 years (P<O'Ol) who in turn had a statistically significant lower bone density than women aged 41-49 years (P<O·Ol). Right femoral neck bone mineral content was lesswell correlated with serum levelsof bone alkaline phosphatase ( Table 1) . The relationship between bone density and serum total alkaline phosphatase was not statistically significant (P>0'05)
The relationship between vertebral bone density or right femoral neck density and the inverse of An inverse relationship was observed between vertebral bone density and serum levels of bonederived alkaline phosphatase (Fig. 1 ). This was highly significant for the group as a whole (P<O·()()l) and also significant within each age decade (Table 1 ). There was also a trend for lower bone densities to be found in older subjects: women aged 41-49 years had bone densities (mean, standard deviation in parentheses) of o· 93 (0'15) gHA/cm 2 (all were premenopausal), women aged 50-59 years had bone densities of 0·81 (0'12) gHA/cm 2 (all were within eight Ann Clin Biochem 1993: 30 Table 1 ). We have found that serum levels of bone alkaline phosphatase and acid phosphatase are significantly positively correlated (P= 0,02, Table 1 ).
P<O·OOl. r=0·55

DISCUSSION
Peak adult bone mass is reached between the third and fourth decades at a time when linear growth has ceased.v" Bone loss occurs steadily thereafter and, around the time of the menopause, there is an increased rate of loss of bone mineral content. During this time there are increases in the rates of both bone formation and resorption but bone density falls because of the relative increase in resorption compared to formation.r" The techniques involved in determining alterations in bone turnover have included analysis of bone biopsies or radiolabelled calcium uptake: 14-16 sensitive serum-based markers of bone turnover such as osteocalcin, osteonectin and procollagen 1 have not been available until recently and are still mainly research tools.v" Serum levels of total alkaline phosphatase are the most commonly used markers of bone formation but lack sensitivity and specificity for bone since these measurements comprise contributions from the liver, intestinal and bone isoenzymes.!? We did not find a significant correlation between bone density and total alkaline phosphatase (or its inverse) but we did demonstrate a highly significant correlation between vertebral bone density and the inverse of the serum activities of bone alkaline phosphatase suggesting that osteoblastic activity rises in association with a fall in bone mineral content ( Table 1 ). An age-related rise in serum levels of total alkaline phosphatase has been described by several groups18-20 and in due to a rise in both the bone and liver isoenzymes. We observed that the rise in bone alkaline phosphatase activity with age, accompanied by falling bone density, was maintained in each decade. Our findings that both the bone-specific fraction of alkaline phosphatase and tartrateresistant acid phosphatase are inversely proportional to bone density in perimenopausal Caucasian women are consistent with an increase in both osteoblastic and osteoclastic activity around the time of the menopause. The findings complement earlier work showing that the serum level of osteocalcin, a 4·9 kD protein synthesised by osteoblasts, rises at the time of the menopause and is inversely related to bone density. [21] [22] [23] [24] The relationship between femoral bone density and serum bone-derived alkaline phosphatase was less well correlated than for vertebral bone density, which may reflect the observation that the mineral content of femora falls some years after that of vertebrae.P Agents which cause bone resorption do not act on osteoclasts directly but appear to produce their effects through the osteoblast.s'" The nature of the intercellular signal is not known. 2-4 This concept of 'coupling' suggests that the activities of osteoblasts and osteoclasts mirror one another and, in support of this, we have demonstrated that activities of bone-derived alkaline phosphatase and tartrate-resistant acid phosphatase in serum are positively correlated.
We conclude that the activities of bone-derived alkaline phosphatase and tartrate-resistant acid phosphatase in serum are inversely proportional to vertebral and femoral neck bone densities: this relationship may prove to be of use in the identification and management of women with low bone density. Christiansen's group26 have used serum total alkaline phosphatase to identify those women most at risk of developing a low bone density. We suggest that use of bone-derived alkaline phosphatase may improve the ability to do so.
